| Date | Source | Headline | |
|---|---|---|---|
| 7th Apr 2025 | 7:00 am | RNS | Holding(s) in Company |
| 4th Apr 2025 | 7:00 am | RNS | Engagement of PharmaVentures |
| 26th Mar 2025 | 7:00 am | RNS | Positive progress on European Patent Application |
| 18th Mar 2025 | 7:00 am | RNS | Update on AWKN-SDN-14 programme |
| 11th Mar 2025 | 9:00 am | RNS | Holding(s) in Company |
| 11th Mar 2025 | 7:00 am | RNS | Appointment of Non-Executive Director |
| 25th Feb 2025 | 7:00 am | RNS-R | Presentation at PharmaSynergyRx Event |
| 24th Feb 2025 | 7:00 am | RNS | Entry into an Arrangement Agreement with Awakn |
| 30th Jan 2025 | 12:00 pm | RNS-R | Proactive Investors interview with Chairman |
| 27th Jan 2025 | 7:00 am | RNS | Update on Awakn Life Sciences’ R&D Progress |
| 24th Jan 2025 | 7:00 am | RNS-R | Investor Presentation |
| 21st Jan 2025 | 2:29 pm | RNS-R | Proactive Investors interview with CEO |
| 21st Jan 2025 | 7:00 am | RNS | Update on FDA Pre-IND Meeting for Awakn |
| 15th Jan 2025 | 7:00 am | RNS-R | Interview with CEO |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.